Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • alezhe
    Junior Member
    • Jan 2013
    • 8

    #1

    required coverage calculation and statistical analysis

    hi
    We are studying genetic variation in populations. So we mix genomic DNAs of several individuals and use it as template to amplify regions of interest.

    According to Roche manual
    40x coverage will result in greater than 99.9% chance of detecting a heterozygote
    What to do if variation frequency is not 0.5 (heterozygote), but, let’s say 0,01 (one heterozygote in 50 individuals).

    According to the same manual
    1% variation of single base changes or multibase deletions 5000x coverage will average 50 reads for a typical variant
    It’s obvious that in case 5000 coverage we expect 50 reads with polymorphic nucleotide.
    In case coverage 500 we must expect 5 polymorphic reads, but have a good chance to get 2-3 polymorphic reads only (and I don’t take into account mixing error), so it might be interpreted as sequencing error as well.

    I’m looking for statistical approaches that will allow define desired coverage and interpret real data to be sure (with some good chance, of course) whether a distinct alignment mismatch is a real polymorphism or just errors.

    Does somebody know usefull links?
    Thanks.
  • Heisman
    Senior Member
    • Dec 2010
    • 534

    #2
    There are pooled sequencing papers out there (SNPSeeker/SPLINTER, CRISP, etc); I'd check those and see what they say.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      Yesterday, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 02:55 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Working...